These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12065866)

  • 1. Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma.
    Fujimoto T; Zhang B; Minami S; Wang X; Takahashi Y; Mai M
    Oncology; 2002; 62(3):201-8. PubMed ID: 12065866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraoperative intraperitoneal administration of mitomycin C and OK-432 for peritoneal dissemination of gastric cancer].
    Sugiyama Y; Yoshida A; Takao H; Kunieda K; Miya K; Azuma S; Tanemura H; Furuta T; Saji S
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1592-5. PubMed ID: 2117890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraoperative chemotherapy with intraperitoneal activated carbon particles adsorbing mitomycin C against peritoneal dissemination of gastric cancer].
    Iwamoto A; Takahashi T; Sasabe T; Itoh M; Kondoh S; Seiki K; Yoneyama C; Shimotsuma M; Hagiwara A; Yamaguchi T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2748-51. PubMed ID: 2506820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
    Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
    Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features and prognosis analysis of mucinous gastric carcinoma.
    Yin C; Li D; Sun Z; Zhang T; Xu Y; Wang Z; Xu H
    Med Oncol; 2012 Jun; 29(2):864-70. PubMed ID: 21298368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
    Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL
    Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative immunochemotherapy for gastric carcinoma with peritoneal dissemination--the effects with the combination of CDDP, 5-FU and lentinan].
    Mio H; Terabe K
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):531-4. PubMed ID: 8129395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil.
    Fanelli MF; Silva MJ; de Paiva TF; Chinen LT; Guimarães AP; Gimenes DL; Pinheiro ED; Rinck JA; Nicolau UR; Sanches SM; Melo CA; Dettino AL; Cruz MR; de Melo LM; Formiga MN; de Lima VC
    Int J Clin Oncol; 2009 Aug; 14(4):326-31. PubMed ID: 19705243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP).
    Kim JY; Bae HS
    Gastric Cancer; 2001; 4(1):27-33. PubMed ID: 11706624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion.
    Maehara Y; Okuyama T; Kakeji Y; Baba H; Furusawa M; Sugimachi K
    Am J Surg; 1994 Jul; 168(1):36-40. PubMed ID: 8024097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 lymph node dissection.
    Imano M; Imamoto H; Itoh T; Satou T; Peng YF; Yasuda A; Kato H; Shiraishi O; Shinkai M; Yasuda T; Takeyama Y; Okuno K; Shiozaki H
    J Surg Oncol; 2012 Jan; 105(1):43-7. PubMed ID: 21837682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of free cancer cells in peritoneal cavity in patients surgically treated for gastric adenocarcinoma].
    Kostić Z; Cuk V; Bokun R; Ignjatović D; Usaj-Knezević S; Ignjatović M
    Vojnosanit Pregl; 2006 Apr; 63(4):349-56. PubMed ID: 16683401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer.
    Hall JJ; Loggie BW; Shen P; Beamer S; Douglas Case L; McQuellon R; Geisinger KR; Levine EA
    J Gastrointest Surg; 2004; 8(4):454-63. PubMed ID: 15120371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of peritoneal lavage cytology at three cavities in patients with gastric cancer.
    Kano Y; Kosugi S; Ishikawa T; Otani T; Muneoka Y; Sato Y; Hanyu T; Hirashima K; Bamba T; Wakai T
    Surgery; 2015 Dec; 158(6):1581-9. PubMed ID: 25958064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive peritoneal washing cytology in multiple cavities can predict poor prognosis of advanced gastric cancer patients.
    Homma Y; Ushida S; Yamada M; Kobayashi H; Suzuki K
    Ann Surg Oncol; 2010 Feb; 17(2):455-60. PubMed ID: 19847567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal administration of the biological response modifier OK-432 and peritoneal recurrence following gastrectomy.
    Tsujitani S; Abe Y; Korenaga D; Saitoh A; Watanabe A; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):498-502. PubMed ID: 2253926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive gastrectomy and carbon-adsorbed mitomycin C for gastric cancer with peritoneal metastases. Case reports of survivors and their implications.
    Hagiwara A; Togawa T; Yamasaki J; Ohgaki M; Imanishi T; Shirasu M; Sakakura C; Yamaguchi T; Sawai K; Yamagishi H
    Hepatogastroenterology; 1999; 46(27):1673-7. PubMed ID: 10430319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma.
    Kuramoto M; Shimada S; Ikeshima S; Matsuo A; Yagi Y; Matsuda M; Yonemura Y; Baba H
    Ann Surg; 2009 Aug; 250(2):242-6. PubMed ID: 19638909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic and Prognostic Features in Patients with Peritoneal Metastasis from Mucinous Adenocarcinoma, Adenocarcinoma with Signet Ring Cells, and Adenocarcinoid of the Appendix Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.
    Ihemelandu C; Sugarbaker PH
    Ann Surg Oncol; 2016 May; 23(5):1474-80. PubMed ID: 26597367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.